IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — ORKA

Balance Sheet

(in billions USD)
MetricQ2 2026Q1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021
Cash & Equivalents0.270.050.090.070.080.410.030.040.040.040.040.050.050.060.060.07
Short-term Investments0.610.340.260.260.27----------------------
Total Current Assets0.880.400.360.330.350.410.030.040.040.040.040.050.050.060.060.07
Property, Plant & Equipment0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Total Non-current Assets*0.250.110.150.030.030.000.000.000.000.000.000.000.000.000.000.00
Total Assets1.140.500.510.360.380.410.030.040.040.040.040.050.050.060.070.07
Accounts Payable------------0.000.000.000.000.000.000.000.000.000.00
Total Current Liabilities0.020.020.020.010.010.020.000.000.000.000.000.000.000.000.000.00
Total Non-current Liabilities*0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Total Liabilities0.020.020.020.010.010.020.000.000.000.000.000.000.000.000.000.00
Retained Earnings(0.26)(0.22)(0.16)(0.13)(0.10)(0.06)(0.19)(0.19)(0.19)(0.19)(0.18)(0.18)(0.18)(0.17)(0.16)(0.16)
Total Stockholder Equity1.110.490.490.340.360.340.030.040.040.040.040.040.050.060.060.07

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021
Total Revenue--------------0.000.000.000.000.000.000.000.000.000.000.000.000.00
Research & Development43.2629.1527.6428.9924.0919.9325.690.130.170.050.320.250.061.021.492.183.943.443.582.88
Selling, General & Admin6.857.296.795.124.345.163.762.992.321.541.621.721.491.531.731.101.741.281.261.23
Total Operating Expenses50.1136.4334.4334.1028.4325.0929.453.122.481.591.941.971.552.553.223.285.684.724.844.10
Operating Income(50.11)(36.43)(34.43)(34.10)(28.43)(25.09)(29.45)(3.12)(2.48)(1.59)(1.94)(1.97)(1.55)(2.55)(3.22)(3.28)(5.68)(4.72)(4.84)(4.10)
Pretax Income--------------------------------(5.68)(4.71)(4.83)--
Tax Provision------------0.00--------------------------
Net Income(41.21)(31.82)(29.58)(30.28)(24.57)(21.00)(28.62)(2.68)(2.01)--(1.42)(1.48)--(2.33)(3.15)(3.27)--(4.71)(4.83)(4.10)
Basic EPS--------(0.46)(0.40)(1.46)(0.18)(0.14)(0.08)(0.10)(0.10)(0.08)(0.16)(0.22)----------
Diluted EPS--------(0.46)(0.40)(1.46)(0.18)(0.14)(0.08)(0.10)(0.10)(0.08)(0.16)(0.22)----------

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021
Operating Cash Flow(33.15)(23.58)(22.59)(21.60)(23.14)(20.87)(34.86)(2.63)(1.53)(1.06)(3.96)(1.59)(1.49)(2.50)(2.62)(4.30)(4.95)(4.87)(3.72)(5.22)
Capital Expenditures0.000.070.060.100.030.010.17----------0.000.000.000.000.010.010.020.01
Free Cash Flow*(33.15)(23.65)(22.66)(21.70)(23.18)(20.88)(35.03)----------(1.49)(2.50)(2.62)(4.30)(4.95)(4.88)(3.74)(5.23)
Investing Cash Flow(410.95)(14.44)(22.02)(122.45)4.8642.87(0.17)0.000.00------0.000.000.00-0.00(0.01)(0.01)(0.02)(0.01)
Financing Cash Flow663.0440.600.30169.91(27.80)27.91450.050.010.00--------------0.000.000.0023.09

* Derived from reported values